Effectiveness of Sildenafil in Erectile Sexual Dysfunction in Prostate Cancer Patients
Introduction: Prostate cancer is the first cause of death by cancer in Cuban men and affects the quality of their sexual life. Objective: To investigate the efficacy of sildenafil in the treatment of erectile dysfunction in patients with prostate cancer after hormone or radiotherapy. Method: An observational, double perspective and cross-sectional study was conducted in the Service of Urology of Hospital “Dr. Agostinho Neto” in Guantanamo from 2014 to 2018, which was approved by the medical ethics committee. The study consisted of 70 patients diagnosed with prostate cancer who received hormone therapy or radiotherapy with erectile dysfunction. In each patient, we studied age, cancer treatment, time of postoperative dysfunction, and the response of penile erectile function to the use of sildenafil. Results: 37.2% of the patients were between 70 and 79 years old, and 79.1% of the patients received hormone therapy; the highest proportion of erectile dysfunction occurred 1–2 years after treatment (48.8%); 81.4% responded adequately to sildenafil treatment, which was not related to hormone or radiotherapy for cancer. Conclusions: Prostate cancer patients treated with hormone and/or radiotherapy benefit from the efficacy of sildenafil.
Faria R, Soares MO, Spackman E, 2018, Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging. Eur Urol, 73:23–30.
Acosta PLY, Correa ML, González GM, et al., 2013, Caracterización clínica-epidemiológica del cáncer de próstata [Clinical Epidemiological Characteristics of Prostate Cancer]. Rev Univ Méd Pinar, 9:2–13.
Bureau of Medical Records and Health Statistics, Ministry of Public Health, Havana, 2018, Health Statistics Yearbook 2018. Available from: http://www.bvs.sld.cu/revistas/anuario.
Monroy GA, Ríos CD, Jiménez LL, et al., 2014, Quality of Sexual Life after Radical Prostatectomy. Rev Mex Urol, 74:169–175. DOI: 10.1016/S2007-4085(15)30032-X.
García VMJ, Rodríguez FM, 2018, Evolution of Nuclear Medicine in the diagnosis and treatment of prostate cancer. Rev Esp Med Nucl Imagen Mol, 37:71–72.
Latin American Federation of Sexology and Sex Education Societies, World Association of Medical Sexology, 2010, Manual Diagnóstico de las enfermedades en Sexología [Diagnostic Manual of Diseases in Sexology] (2nd edn.). Caracas: CIPV.
McCabe MP, Sharlip ID, Lewis R, et al., 2016, Risk Factors for Sexual Dysfunction among Women and Men: A Consensus Statement from the Fourth International Consultation on Sexual Medicine in 2015. The Journal of Sexual Medicine, 13:153–67. DOI: 10.1016/j.jsxm.2015.12.015.
American Psychiatric Association, 2013, Desk Reference to the Diagnostic Criteria of Dsm-5tm. Arlington, VA: American Psychiatric Association.
Ruiz CJL, Lorenzo SL, Ramos SD, et al., 2018, Implicaciones de la estratificación del cáncer de próstata localizado [Implications of Localized Prostate Cancer Stratification]. Actas Urol Esp, 42:103–13.
Sanchis BA, Barrionuevo GM, Bajo CAM, et al., 2018, Validation of the Prostate Health Index in a Predictive Model of Prostate Cancer. Actas Urol Esp, 42:25–32. DOI: 10.1016/j.acuro.2017.06.003.
Vallejos J, Villaronga A, Alvarez C, et al., 2013, Staging of Prostate Cancer: An Update. Rev Argent Radiol, 77:301–5. DOI: 10.7811/rarv77n4a10.
Albertson M, Mwamukonda KB, Shindel AW, et al., 2011, Evaluation and Treatment of Erectile Dysfunction. Med Clin North Am, 95:201–12. DOI: 10.1016/j.mcna.2010.08.016.
Ceballos MP, Villlaraga ADJ, Silva HJM, et al., 2015, Guía de disfunción eréctil [Guide to Erectile Dysfunction]. Uro Colomb, 24:185.
Linares Espinón E, Barret E, Sivaraman JA, et al., 2016, Tratamiento focal del cáncer de próstata localizado [Local Treatment of Localized Prostate Cancer]. Arc Esp Urol, 69:345–52.
Rosen RC, Riley A, Wagner G, et al., 1997, The International Index of Erectile Function (IIEF): A Multidimensional Scale for Assessment of Erectile Dysfunction. Urology, 49:822–30.
Bella JA, Lee J, Carrier S, et al., 2015, 2015 CUA Practice Guidelines for Erectile Dysfunction. Can Urol Assoc J, 9:23–9.
Ruiz-Aragón J, Márquez-Peláez S, Luque Romero LG, 2010, Erectile Dysfunction in Patients with Prostate Cancer Who Have Undergone Surgery: Systematic Review of Literature. Actas Urol Esp, 34:677–85.
Katelaris N, Murphy D, Lawrentschuk N, et al., 2016, Cytoreductive Surgery for Men with Metastatic Prostate Cancer. Prostate Int, 4:103–6.
Ortega BG, Castillo DZE, 2015, Hormonal Treatment with Zoladex plus Casodex in Geriatric Patients with Prostatic Cancer. Medicentro, 19:59–60.
Comas I, Ferrer R, Planas J, 2018, A Systematic Review of Methods for Quantifying Serum Testosterone in Patients with Prostate Cancer Who Underwent Castration. Actas Urol Esp, 42:86–93.